Considering all these data, our study evaluated the role of presepsin, procalcitonin, and CRP in the early diagnosis of bacterial infections in cirrhotic patients admitted with ACLF, defined according to the European Association for the Study of the Liver-Chronic Liver Failure Consortium (EASL-CLIF) criteria. This evidence concerns the gene CRP and chronic liver failure.